Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (2) , 225-230
- https://doi.org/10.1016/j.ejca.2004.08.026
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Experience in the treatment of dedifferentiated chondrosarcomaThe Journal of Bone and Joint Surgery. British volume, 2000
- Neoadjuvant Chemotherapy With Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup StudyJournal of Clinical Oncology, 1999
- Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma IntergroupThe Lancet, 1997
- A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.Journal of Clinical Oncology, 1992
- Chondrosarcoma and other rare bone sarcomasCurrent Opinion in Oncology, 1990
- Mesenchymal chondrosarcoma a clinicopathologic analysis of 35 patients with emphasis on treatmentCancer, 1983
- Chemotherapy of malignant fibrous histiocytoma of bone: A report of five casesCancer, 1983
- Adjuvant chemotherapy of malignant fibrous histiocytoma of boneCancer, 1983